Our consolidated sales for the third quarter of 2021 were US$473.2 million, an increase of 22% compared to US$388.3 million in the same period last year. Sales for the third quarter of 2021 include $20 million in sales related to our acquisition of Normerica. The beneficial effect of foreign exch